BML Capital Management, LLC ACRS Holdings History
BML Capital Management, LLC's Aclaris Therapeutics Inc Holding Summary
As of 2025-03-31, BML Capital Management, LLC held 14.25 Mil shares of Aclaris Therapeutics Inc(ACRS), totaling $21.80 Mil. This investment constitutes 17.65% of their stock portfolio, and BML Capital Management, LLC now holds 13.16% of the outstanding Aclaris Therapeutics Inc(ACRS) stock.
The initial trade took place in 2023Q4. And since then BML Capital Management, LLC has made 4 purchases of ACRS, at an average price of $1.27, for a total of 14.25 Mil shares. Based on historical transaction data and ACRS's current price of $1.62, BML Capital Management, LLC's estimated gain on his ACRS holdings is $4.93 Mil, reflecting a 27.18% gain to date.
BML Capital Management, LLC ACRS ($1.62) Holding Chart
BML Capital Management, LLC ACRS ($1.62) Quarterly Buys and Sells
| Period | Bought/Sold (Sh.) | % Change | Qtr. End Shares | Avrg. Price |
|---|---|---|---|---|
| Shares Bought | 0 | Average Price $-/Share | ||
| Shares Sold | 0 | Average Price $-/Share | ||
| Current Price $0.00 | Total Estimated Gain 0 % | |||
Top Ranked Articles
- 1
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
